COPD: it is time to change!

References

• Global Initiative for Chronic Obstructive Pulmonary DiseaseGlobal strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary DiseaseGlobal Initiative for Chronic Obstructive Pulmonary Disease: 2014 Available from: http//www.goldcopd.org/uploads/users/files/GOLD_Report_2014_Jun11.pdfAccessed December 15, 2014
   Google Scholar
• MennPHeinrichJHuberRMKORA Study GroupDirect medical costs of COPD – an excess cost approach based on two population-based studiesRespir Med201210654054822100535
   PubMed Web of Science ®Google Scholar
• ThunMJCarterBDFeskanichD50-year trends in smoking-related mortality in the United SatesN Engl J Med201336835136423343064
   PubMed Web of Science ®Google Scholar
• MurrayCJLPhilDLopezADMeasuring the global burden of diseaseN Engl J Med201336944845723902484
   PubMed Web of Science ®Google Scholar
• ERS White BookThe Burden of Lung DiseaseSheffieldERS White Book2013 Chapt 1:1–15 and COPD Chapt 13:1–12
   Google Scholar
• World Health OrganizationBurden of COPDGenevaWorld Health Organization2014
   Google Scholar
• BurrowsBFletcherCMHeardBEJonesNLWootliffJSThe emphysematous and bronchial types of chronic airways obstruction. A clinicopathological study of patients in London and ChicagoLancet196618308354159957
   PubMed Web of Science ®Google Scholar
• HoggJCChuFUtokaparchSThe nature of small-airway obstruction in chronic obstructive pulmoinary diseaseN Engl J Med20043502645265315215480
   PubMed Web of Science ®Google Scholar
• ErikssonSPulmonary emphysema and alpha-1-antitrypsin deficiencyActa Med Scand196417519720514124635
   PubMed Web of Science ®Google Scholar
• FinkelsteinRFraserRSGhezzoHCosioMAlveolar inflammation and its relation to emphysema in smokersAm J Respir Crit Care Med1995152166616727582312
   PubMed Web of Science ®Google Scholar
• KimWDEidelmanDHIzquierdoJLGhezzoHSaettaMPCosioMCentrilobular and panlobular emphysema in smokers. Two distinct morphologic and functional entitiesAm Rev Respir Dis1991144138513901741553
   PubMed Web of Science ®Google Scholar
• McDonoughJEYuanRSuzukiMSmall-airway obstruction and emphysema in chronic obstructive pulmonary diseaseN Engl J Med20113651567157522029978
   PubMed Web of Science ®Google Scholar
• BrightlingCEMcKennaSHargadonBSputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary diseaseThorax20056019319815741434
   PubMed Web of Science ®Google Scholar
• LeeJ-HLeeYKKimE-KKimT-HResponse to inhaled long-acting beta-agonist and corticosteroid according to COPD subtypeRespir Med201010454255119926461
   PubMed Web of Science ®Google Scholar
• SivaRGreenRHBrightlingCEEosinophilic airway inflammation and exacerbations of COPD: a randomized controlled trialEur Respir J20072990691317301099
   PubMed Web of Science ®Google Scholar
• Di SantostefanoRLLiHRubinDBStempelDAWhich patients with chronic obstructive pulmonary disease benefit from the addition of an inhaled corticosteroid to their bronchodilator? A cluster analysisBMJ Open2013343e001838
   Web of Science ®Google Scholar
• LieskerJJWBathoornEPostmaDSVonkJMTimensWKerstjensAMSputum inflammation predicts exacerbations after cessation of inhaled corticosteroids in COPDRespir Med20111051853186021802933
   PubMed Web of Science ®Google Scholar
• LapperreTSSnoeck-StrobandJBGosmanMMGroningen Leiden Universities Corticosteroids in Obstructive Lung Disease Study GroupEffect of fluticasone with and without salmeterol on pulmonary outcomes in chronic obstructive pulmonary diseaseAnn Intern Med200915151752719841453
   PubMed Web of Science ®Google Scholar
• NishimuraMMakitaHNagaiKHokkaido COPD Cohort Study InvestigatorsAnnual Change in pulmonary function and clinical phenotype in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2012185445222016444
   PubMed Web of Science ®Google Scholar
• JohannessenASkorgeTDBottaiMMortality by level of emphysema and airway wall thicknessAm J Respir Crit Care Med201318760260823328525
   PubMed Web of Science ®Google Scholar
• HershCPMakeBJLynchDACOPDGene and ECLIPSE InvestigatorsNon-emphysematous chronic obstructive pulmonary disease is associated with diabetes mellitusBMC Pulm Med20141416425341556
   PubMed Web of Science ®Google Scholar
• HanMKKazerooniEALynchDACOPDGene InvestigatorsChronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypesRadiology201126127428221788524
   PubMed Web of Science ®Google Scholar
• PuhanMAGarcia-AymerichJFreyMExpansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADOindexLancet200937470471119716962
   PubMed Web of Science ®Google Scholar
• AgustíAEdwardsLDRennardSIEvaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) InvestigatorsPersistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotypePLoS One201275e3748322624038
   PubMed Web of Science ®Google Scholar
• HurstJRExacerbation phenotyping in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med201118462562621920921
   PubMed Web of Science ®Google Scholar
• DivoMCoteCde TorresJPBODE Collaborative GroupComorbidities and risk of mortality in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med201218615516122561964
   PubMed Web of Science ®Google Scholar
• MiravittlesMSoler-CatalunaJJCalleMSpanish guideline for COPD (gesEPOC). Update 2014Arch Bronconeumol201448suppl 1258
   Google Scholar
• JenkinsCRJonesPWCalverleyPMEfficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomized placebo-controlled TORCH studyRespir Res200910596819566934
   PubMed Web of Science ®Google Scholar
• DecramerMCelliBKestenSUPLIFT InvestigatorsEffect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomized controlled trialLancet20093741171117819716598
   PubMed Web of Science ®Google Scholar
• HurstJRVestboJAnzuetoASusceptibility to exacerbation in chronic obtructive pulomary diseaseNew Engl J Med2010631128113820843247
   PubMed Web of Science ®Google Scholar
• LinCLSiuLKLinJCMannose-binding lectine gene polymorphism contributes to the recurrence of exacerbation in patients with COPDChest2011139435120688922
   PubMed Web of Science ®Google Scholar
• ForemanMGDeMeoDLHershCPPolymorphic variation in surfactant protein B is associated with COPD exacerbationsEur Respir J20083293894418550614
   PubMed Web of Science ®Google Scholar
• MalliaPMessageSDGielenVExperimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbationAm J Respir Crirt Care Med2011183734742
   PubMed Web of Science ®Google Scholar
• DonaldsonGCMüllerovaHLocantoreNFactors associated with change in exacerbation frequency in COPDRespir Res201314798823899210
   PubMed Web of Science ®Google Scholar
• WedzichaJARabeKFMartinezFJEfficacy of roflumilast in the COPD frequent exacerbator phenotypeChest20131431302131123117188
   PubMed Web of Science ®Google Scholar
• Soler-CatalunaJJMartìnez-GarcìaMARomàn SanchezPSalcedoENavarroMOchadoRSevere acute exacerbation and mortality in patients with chronic obstructive pulmonary diseaseThorax20056092593116055622
   PubMed Web of Science ®Google Scholar
• BafadhelMMcKennaSTerrySAcute exacerbations of chronic obstructive pulmonary disease. Identification of biollogic clusters and their biomarkersAm J Respir Crirt Care Med2011184662671
   PubMed Web of Science ®Google Scholar
• WedzichaJADecramerMSeemungalARThe role of bronchodilators in the prevention of exacerbation of COPDEur Respir J2012401545155422835613
   PubMed Web of Science ®Google Scholar
• WedzichaJADecramerMFickerJHAnalysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopironium and tiotropium (SPARK): a randomized, double-blind, parallel-group studyLancet Respir Med2013119920924429126
   PubMed Web of Science ®Google Scholar
• SeemungalTARWilkinsonTMAHurstJRPereraWRSapsfordRJWedzichaJALong-term erytromycin therapy is associated with dcreased chronic obstructive pulmonary disease exacerbationsAm J Respir Crti Care Med200817811391147
   PubMed Web of Science ®Google Scholar
• AlbertRKConnettJBaileyWCCOPD Clinical Research NetworkAzithromicin for prevention of exacerbations of COPDNew Engl J Med201136568969821864166
   PubMed Web of Science ®Google Scholar
• UzunSDjaminRSKluytmansJAAzithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): a randomized, double-blind, placebo-controlled trialLancet Respir Med2014236136824746000
   PubMed Web of Science ®Google Scholar
• WashkoGRFanVSRamseySDNational Emphysema Treatment Trial Research GroupThe effect of lung volume reduction surgery on chronic obstructive pulmonary disease exacerbationsAm J Respir Crirt Care Med2008177164169
   PubMed Web of Science ®Google Scholar
• MarinJMSorianoJBCarrizoSJBoldovaACelliBROutcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea. The overlap sindromeAm J Respir Crirt Care Med2010182325331
   PubMed Web of Science ®Google Scholar
• LehouckAMathieuCCarremansCHigh does of Vitamin D to reduce exacerbations in chronic obstructive pulmonary diseaseAnn Intern Med201215610511422250141
   PubMed Web of Science ®Google Scholar
• ZhengJPKangJHuangSGEffect of carbocistein on acute exacerbation of chronic obstructive pulmonary disease (PEACE study): a randomized placebo-controlled studyLancet20083712013201818555912
   PubMed Web of Science ®Google Scholar
• ZhengJPWenFQBaiCXOn behalf of the PANTHEON study groupTwice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trialLancet Respir Med2014218719424621680
   PubMed Web of Science ®Google Scholar
• VestboJAndersonJACalverleyPMAdherence to inhaled therapy, mortality and hospital admission in COPDThorax20096493994319703830
   PubMed Web of Science ®Google Scholar